Search

FDA Variance Application from J.M.W. Entertainment Group

The FDA has posted a variance application from The J.M.W. Entertainment Group, LLC. This document is available for review on the Regs.gov platform. No further details on the nature of the variance or its implications are provided in the notice.

FDA Complaint Document Details

The FDA has posted details regarding a complaint document, with the information made available on March 16, 2026. The document is related to a complaint filed with the agency.

FDA Acknowledgment Letter to J.M.W. Entertainment Group

The FDA issued an acknowledgment letter to The J.M.W. Entertainment Group, LLC, regarding a submission. This notice confirms receipt of documentation by the FDA's Center for Devices and Radiological Health (CDRH).

FDA Complaint Document Posted

The FDA has posted a complaint document related to its regulatory activities. The document was made available on March 16, 2026, and was open for public comment. No specific details about the complaint's content or the nature of the comment period are provided.

FDA Document on Contraceptive Status Among Females 15-49

The Food and Drug Administration (FDA) has issued a document concerning contraceptive status among females aged 15-49. This notice provides information on the topic without introducing new regulatory requirements.

FDA Variance Application from Audio Source, Inc

The FDA has posted a variance application from Audio Source, Inc. This document is available for review on the Regs.gov platform. The application pertains to medical device regulations.

FDA Variance Amendment from J.M.W. Entertainment Group

The FDA has posted a variance amendment from J.M.W. Entertainment Group, LLC. The document was made available on March 16, 2026, via the Regs.gov portal. No further details on the amendment's content are provided.

FDA Complaint Document

The FDA has posted a complaint document related to its activities, with the comment period closing on March 16, 2026. The document is available for public review and input.

FDA Background Material on Contraceptive Use and HIV-1 Transmission Risk

The FDA has posted background material concerning contraceptive use and the risk of HIV-1 transmission. This notice provides scientific information relevant to public health discussions and regulatory considerations.

FDA Acknowledgment Letter to Audio Source, Inc

The FDA has issued an acknowledgment letter to Audio Source, Inc. regarding a submission. This notice confirms receipt of the document by the agency.